Market news
TypeAll
SortNewest
Assets
PPBT
Purple Biotech U.S. Patent Allowance Strengthens CAPTN-3 Multispecific Antibody Protection
Purple Biotech (NASDAQ:PPBT) has received a U. S.
Sep 2Yahoo Finance
PPBT
Sep 2BenzingaPPBT
Top Midday Gainers
Purple Biotech (PPBT) said Wednesday that the US Patent and Trademark Office has issued a "Notice of
Sep 2Yahoo FinancePPBT
Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform
Achieved commercially viable yield for IM1240, positioning the program competitively for future development Validates scalability of the CAPTN-3...
Aug 28Barchart.comPPBT
Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update
Initiated development of a second CAPTN-3 tri-specific antibody targeting TROP2 Manufacturing milestone achieved for IM1240, the first tri-specific...
Aug 28Barchart.comPPBT
Aug 10Investing.comPPBT
Aug 7Yahoo Finance SingaporePPBT
Purple Biotech Sets September 8, 2026 AGM to Reshape Board Roles and Compensation Policy
Detailed price information for Purple Biotech Ltd ADR (PPBT-Q) from The Globe and Mail including charting and trades.
Jul 30The Globe and MailPPBT
This is the newest page. Registered accounts read further back.